From January 30 to February 1, 2024, LaserBlood was presented at Photonics West Exhibition in San Francisco, California. This globally renowned event is a hub for innovation in photonics and biomedical optics.
During the conference, our team introduced the concept of using fluorescence lifetime analysis for early detection of pancreatic cancer, highlighting the project’s interdisciplinary approach combining nanotechnology and biophotonics. The event provided an excellent opportunity to network with the photonics community and gain valuable insights into emerging technologies.